Login

Regeneus ASX:RGS May 2021 Business Update - Karolis Rosickas, CEO, Regeneus Ltd 00:00:00

Share On Facebook Share On Twitter

Regeneus ASX:RGS May 2021 Business Update

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
KBC Bank's Strong Performance in Q3 2023: Robust Profit and Strategic Initiatives | Johan Thijs, CEO, KBC Bank.
00:10:00
Key Tenets of Coronation Fund Managers' Investment Philosophy | karl leinberger , CIO, South Africa Coronation Fund Managers.
00:10:00
Evolution of Independent Wealth Management | Brian O'Neal, President, Cahaba Wealth Management, Inc
00:10:00
Innovative Diamond Exploration Solutions with On-Site Processing
00:10:00
Gold's Surge: Does It Belong in Your Portfolio?
00:10:00
David Stein Discusses Investing in Junior Mining and Kuya Silver's Strategy
00:10:00
Client Success Story: The Childress Family's Financial Journey | The Childress Family, Clients of Goldstone Financial Group
00:10:00
Building a Venture Firm for Diverse Founders with creativity|Jarrid Tingle,Co-Founder and Managing Partner,Harlem Capital Partners
00:00:00
Medivir - ABGSC Life Summit May 18 2022 - Jens Lindberg, CEO, Medivir
00:10:00
John Yoo on the Framers' Debate Over Executive Power|John Yoo
00:10:00
Protecting Your Credit and Personal Data: Insights from Kim Curtis
00:10:00
TD Ameritrade to Schwab Q3 Transition: Scam Alert | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege

© 2026 Nehu